TIME COURSE OF VISUAL ACUITY CHANGES WITH INTRAVITREAL AFLIBERCEPT (IVT-AFL) OR MACULAR LASER PHOTOCOAGULATION IN PATIENTS WITH DIABETIC MACULAR EDEMA (DME): OUTCOMES FROM THE VIVID-DME AND VISTA-DME CLINICAL TRIALS

被引：1

作者：

McAllister, Ian ^{[1
]}

Holz, Frank ^{[2
]}

Metzig, Carola ^{[3
]}

机构：

[1] Lions Eye Inst, Perth, WA, Australia

[2] Univ Bonn, Bonn, Germany

[3] Bayer Healthcare, Berlin, Germany

来源：

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2014年 / 42卷

关键词：

D O I：

10.1111/ceo.12446

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

0504

引用

页码：13 / 13

页数：1

共 32 条

[1] Rapid Response to Intravitreal Aflibercept (IVT-AFL) in Patients with Diabetic Macular Edema (DME) in the Vivid-dme and Vista-DME Trials
Varano, Monica
Korobelnik, Jean-Francois
Parravano, Mariacristina
Katz, Todd A.
Metzig, Carola
[J]. OPHTHALMOLOGICA, 2014, 232 : 22 - 22
[2] Intravitreal Aflibercept (IVT-AFL) for Diabetic Macular Edema (DME): 3 Year Data from VIVID-DME and VISTA-DME
Staurenghi, G.
Metzig, C.
[J]. ACTA OPHTHALMOLOGICA, 2015, 93
[3] Rescue Therapy Use in Patients with Diabetic Macular Edema (DME) Receiving Intravitreal Aflibercept (IVT-AFL) or Laser: Results from the VIVID-DME and VISTA-DME Trials
Rehak, Matus
Korobelnik, Jean-Francois
Metzig, Carola
[J]. OPHTHALMOLOGICA, 2014, 232 : 17 - 18
[4] Impact of Intravitreal Aflibercept (IVT-AFL) on Diabetic Retinopathy in the VIVID-DME and VISTA-DME Studies
Larsen, L. M.
Metzig, C.
[J]. ACTA OPHTHALMOLOGICA, 2015, 93
[5] INTRAVITREAL AFLIBERCEPT FOR THE TREATMENT OF DIABETIC MACULAR EDEMA (DME): FINDINGS FROM THE VIVID-DME AND VISTA-DME CLINICAL TRIALS
Midena, E.
[J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2014, 24 (03) : 459 - 459
[6] Evaluation of Intravitreal Aflibercept for Treatment of Diabetic Macular Edema: Visual Acuity Subgroups in VIVID-DME and VISTA-DME
Lorenz, Katrin
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
[7] Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: A review of VIVID-DME and VISTA-DME data
Ziemssen F.
Schlottman P.G.
Lim J.I.
Agostini H.
Lang G.E.
Bandello F.
[J]. International Journal of Retina and Vitreous, 2 (1)
[8] Impact of Prior Therapy for Diabetic Macular Edema (DME) on Visual and Anatomic Outcomes Following Treatment with Intravitreal Aflibercept: Results from the Phase 3 VISTA-DME and VIVID-DME Studies
Quan Dong Nguyen
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
[9] Intravitreal Aflibercept Injection (IAI) for Diabetic Macular Edema (DME): Primary and Additional Endpoint Results from the 12-Month Phase 3 VISTA-DME and VIVID-DME Studies
Brown, David M.
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
[10] THE COST-EFFECTIVENESS (CE) OF INTRAVITREAL AFLIBERCEPT (IVT-AFL) IN THE TREATMENT OF DIABETIC MACULAR EDEMA (DME) IN TURKEY
Deger, C.
Ozdemir, O.
Eldem, B.
Unlu, N.
Alp, M. N.
Saatci, A. O.
Ozmert, E.
Altintas, A. K.
Sermet, F.
Erdal, E.
Sar, C.
Asan, S.
Sumer, F.
Parali, E.
Ozel, O.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A606 - A606

← 1 2 3 4 →